
Lamassu Pharma: A biotech startup driving medical solutions through innovative translational research.
Lamassu Pharma, founded with a mission to accelerate hope and healing, is a biotech startup dedicated to solving unmet medical needs through innovative translational research. The company focuses on bridging the gap between academia and industry to bring transformational treatments to patients more quickly. Their core offerings include developing science-driven, innovative solutions aimed at meeting critical patient needs, particularly in areas where current treatment options are limited.
Notable figures associated with Lamassu Pharma include a team of dedicated physicians, engineers, and translational scientists who are passionate about treating patients like family. The company has garnered attention for its collaborative approach and has established partnerships with key academic and industry players. Lamassu Pharma's impact is marked by its commitment to accelerating the treatment process, thereby aiming to save more lives and improve patient outcomes significantly.

Auxilius Pharma
auxiliuspharma.com

Camino Pharma
caminopharma.com

Intellimedix

PleoPharma
pleopharma.com

Essential Remedium

Faze Medicines
fazemed.com

iQure Pharma
iqurepharma.com

EIR Pharmaceuticals

Stramsen Biotech

Manhattan Pharmaceuticals

Celdara Medical

Curie.Bio
curie.bio

Reset Pharmaceuticals

PhagePro
phageproinc.com

Woolsey Pharmaceuticals
woolseypharma.com
Companies similar to Lamassu Pharma include Auxilius Pharma, Camino Pharma, Intellimedix and PleoPharma.
Lamassu Pharma was founded in 2018.
Lamassu Pharma's headquarters is located in Durham, NC, US.
Lamassu Pharma's most recent funding round was for $2.7M (USD) in April 2020.
As of Apr 29, 2020, Lamassu Pharma has raised a total of $2.7M (USD).
Lamassu Pharma has 6 employees as of Feb 5, 2024.